Other Liabilities - Skye Bioscience Inc (NASDAQ:SKYE) - Alpha Spread

Skye Bioscience Inc
NASDAQ:SKYE

Watchlist Manager
Skye Bioscience Inc Logo
Skye Bioscience Inc
NASDAQ:SKYE
Watchlist
Price: 5.49 USD 4.77% Market Closed
Market Cap: 154.1m USD
Have any thoughts about
Skye Bioscience Inc?
Write Note

Skye Bioscience Inc
Other Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Skye Bioscience Inc
Other Liabilities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Other Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Other Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Skye Bioscience Inc
NASDAQ:SKYE
Other Liabilities
$129.9k
CAGR 3-Years
N/A
CAGR 5-Years
-24%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Other Liabilities
$32.4B
CAGR 3-Years
4%
CAGR 5-Years
15%
CAGR 10-Years
27%
Gilead Sciences Inc
NASDAQ:GILD
Other Liabilities
$2.2B
CAGR 3-Years
-28%
CAGR 5-Years
-22%
CAGR 10-Years
15%
Amgen Inc
NASDAQ:AMGN
Other Liabilities
$4.6B
CAGR 3-Years
-19%
CAGR 5-Years
-13%
CAGR 10-Years
-3%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Other Liabilities
$1.5B
CAGR 3-Years
30%
CAGR 5-Years
57%
CAGR 10-Years
37%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Other Liabilities
$1.7B
CAGR 3-Years
37%
CAGR 5-Years
11%
CAGR 10-Years
23%

See Also

What is Skye Bioscience Inc's Other Liabilities?
Other Liabilities
129.9k USD

Based on the financial report for Jun 30, 2024, Skye Bioscience Inc's Other Liabilities amounts to 129.9k USD.

What is Skye Bioscience Inc's Other Liabilities growth rate?
Other Liabilities CAGR 5Y
-24%

Over the last year, the Other Liabilities growth was -38%.

Back to Top